← Leaderboards
Timothy J Hohman
Vanderbilt University Medical Center
$27,192,726
Attributed
$57,614,968
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.9M · FY2016–25$20M$15M$10M$5M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$57,614,968 · 9
By mechanism
U24$37,497,984 · 1
R01$17,872,643 · 4
P20$762,563 · 1
K01$594,571 · 1
P30$452,707 · 1
R21$434,500 · 1
Top collaborators
- Michael L Cuccaro5 shared
- Oscar Harari5 shared
- Catherine Cook Kaczorowski5 shared
- Arthur W Toga5 shared
- Rachel Frances Buckley3 shared
- Michael C Donohue3 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Angela L. Jefferson$48,680,773
- E Wesley Ely$22,934,169
- Christopher Hughes$4,805,721
- Mayur B Patel$10,041,667
- Jin Ho Han$4,859,012
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseGeneticResilienceNeuropathologyGenomicsImpaired CognitionPathway InteractionsBrainCognitiveGenetic MarkersGenesPhenotypeResourcesCohortInnovationNerve DegenerationTherapeutic InterventionAutopsyGene ExpressionSymptomsCohort StudiesGenetic ArchitectureBiological Markers
Grant awards (37)
Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium$8,370,718
U24 · FY2025 · AG · contact PI
Systems Genetics Analysis of Sex Differences in Alzheimer's Disease$1,131,658
R01 · FY2025 · AG
Building predictive algorithms to identify resilience and resistance to Alzheimer's disease$962,469
R01 · FY2025 · AG
Vanderbilt Alzheimer's Disease Research Center: Biomarker Core$452,707
P30 · FY2025 · AG · contact PI
Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium$8,518,767
U24 · FY2024 · AG · contact PI
Systems Genetics Analysis of Sex Differences in Alzheimer's Disease$1,189,985
R01 · FY2024 · AG
MVP Data Integration into the ADSP Phenotype Harmonization Consortium$1,142,026
U24 · FY2024 · AG · contact PI
Building predictive algorithms to identify resilience and resistance to Alzheimer's disease$1,032,210
R01 · FY2024 · AG
Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium$6,176,205
U24 · FY2023 · AG · contact PI
Systems Genetics Analysis of Sex Differences in Alzheimer's Disease$1,400,225
R01 · FY2023 · AG
Building predictive algorithms to identify resilience and resistance to Alzheimer's disease$1,042,897
R01 · FY2023 · AG
Neuroprotective Effects of Vascular Endothelial Growth Factor in Alzheimer's Disease$807,979
R01 · FY2023 · AG · contact PI
Biomarker Core$54,362
P20 · FY2023 · AG · contact PI
Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium$6,455,218
U24 · FY2022 · AG · contact PI
Systems Genetics Analysis of Sex Differences in Alzheimer's Disease$1,235,110
R01 · FY2022 · AG
Neuroprotective Effects of Vascular Endothelial Growth Factor in Alzheimer's Disease$817,176
R01 · FY2022 · AG · contact PI
Genetic Drivers of Resilience to Alzheimer's Disease$776,683
R01 · FY2022 · AG · contact PI
Biomarker Core$422,358
P20 · FY2022 · AG · contact PI
Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium$6,835,050
U24 · FY2021 · AG · contact PI
Systems Genetics Analysis of Sex Differences in Alzheimer's Disease$1,282,851
R01 · FY2021 · AG
Neuroprotective Effects of Vascular Endothelial Growth Factor in Alzheimer's Disease$837,506
R01 · FY2021 · AG · contact PI
Genetic Drivers of Resilience to Alzheimer's Disease$779,990
R01 · FY2021 · AG · contact PI
Biomarker Core$155,095
P20 · FY2021 · AG · contact PI
Neuroprotective Effects of Vascular Endothelial Growth Factor in Alzheimer's Disease$853,100
R01 · FY2020 · AG · contact PI
Genetic Drivers of Resilience to Alzheimer's Disease$782,680
R01 · FY2020 · AG · contact PI
Biomarker Core$130,748
P20 · FY2020 · AG · contact PI
Genetic Resilience to the Clinical Manifestation of Dementia$118,534
K01 · FY2020 · AG · contact PI
Neuroprotective Effects of Vascular Endothelial Growth Factor in Alzheimer's Disease$900,827
R01 · FY2019 · AG · contact PI
Genetic Drivers of Resilience to Alzheimer's Disease$785,860
R01 · FY2019 · AG · contact PI
Genetic Drivers of Resilience to Alzheimer's Disease$406,524
R01 · FY2019 · AG · contact PI
Sex-Specific Genetic Drivers of Alzheimer's Disease Neuropathology$197,500
R21 · FY2019 · AG · contact PI
Genetic Resilience to the Clinical Manifestation of Dementia$118,729
K01 · FY2019 · AG · contact PI
Genetic Drivers of Resilience to Alzheimer's Disease$846,913
R01 · FY2018 · AG · contact PI
Sex-Specific Genetic Drivers of Alzheimer's Disease Neuropathology$237,000
R21 · FY2018 · AG · contact PI
Genetic Resilience to the Clinical Manifestation of Dementia$118,919
K01 · FY2018 · AG · contact PI
Genetic Resilience to the Clinical Manifestation of Dementia$119,103
K01 · FY2017 · AG · contact PI
Genetic Resilience to the Clinical Manifestation of Dementia$119,286
K01 · FY2016 · AG · contact PI